All filters
Abstracts
Inflammation Affects Antiretrovirals Plasma and Intracellular Exposure
M. Ferrara Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Lack of a Pharmacokinetic (PK) Interaction Between HIV-1 Maturation Inhibitor (MI) GSK3640254 (GSK’254) and Oral Contraceptive (OC) Ethinyl Estradiol (EE)/Levonorgestrel (LNG)
S. Joshi Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Lack of a Pharmacokinetic (PK) Interaction Between HIV-1 Maturation Inhibitor (MI) GSK3640254 and Dolutegravir
T. Pene Dumitrescu  Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Antiretroviral Drug-drug Interaction (DDI) Profile of Long-acting Cabotegravir and Rilpivirine
P. Patel Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Fostemsavir Drug-Drug Interaction Profile, an Attachment Inhibitor and Oral Prodrug of Temsavir, for Patients With Multidrug Resistant HIV-1 Infection
K. Moore Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Open-Label, Drug-Drug Interaction Study between HIV-1 Maturation Inhibitor (MI) GSK3640254 and Tenofovir Alafenamide (TAF)/Emtricitabine (FTC) in Healthy Participants
T. Pene Dumitrescu Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple Ascending Doses of Jnj-64417184, a Non-Nucleoside Inhibitor of Respiratory Syncytial Virus Polymerase, in Healthy Volunteers
M. Pastagia Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Single-Ascending Dose (SAD) Pharmacokinetics of Hepatitis B Virus (HBV)-Specific JNJ-73763989 in Non-Japanese and Japanese Healthy Volunteers (HV)
T. Kakuda Reviews in Antiviral Therapy & Infectious Diseases 4, 2020
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Videos
Leveraging Reverse Transcriptase 2020 | Judith Currier
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase 2020 | Anton Pozniak
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase 2020 | Laura Waters
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase 2020 | Jean-Michel Molina
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase 2020 | Chloe Orkin
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase 2020 | Martin Markowitz
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase 2020 | Daniel Kuritzkes
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Videos
Leveraging Reverse Transcriptase in HIV | Judith Currier
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Abstracts
Acceptability and concerns over the use of PrEP in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Slidesets
Leveraging Reverse Transcriptase | Pozniak
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Slidesets
Leveraging Reverse Transcriptase 2020 | Waters
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Slidesets
Leveraging Reverse Transcriptase 2020 | Molina
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020
Slidesets
Leveraging Reverse Transcriptase 2020 | Orkin
Presented at:
Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020